All
Images
Videos
Maps
News
Shopping
More
Flights
Travel
Hotels
Notebook
Report an inappropriate content
Please select one of the options below.
Not Relevant
Offensive
Adult
Child Sexual Abuse
Length
All
Short (less than 5 minutes)
Medium (5-20 minutes)
Long (more than 20 minutes)
Date
All
Past 24 hours
Past week
Past month
Past year
Resolution
All
Lower than 360p
360p or higher
480p or higher
720p or higher
1080p or higher
Source
All
Dailymotion
Vimeo
Metacafe
Hulu
VEVO
Myspace
MTV
CBS
Fox
CNN
MSN
Price
All
Free
Paid
Clear filters
SafeSearch:
Moderate
Strict
Moderate (default)
Off
Filter
Top results
Durvalumab FDA Approval for Bladder Cancer
Apr 22, 2017
onclive.com
Durvalumab (Imfinzi) FDA Approved for Stage III NSCLC: Standard of Care?
10 views
Dec 15, 2019
vumedi.com
A New Immunotherapy for Bladder Cancer
Feb 10, 2020
aacr.org
Nuspojave Imfinzi (durvalumab), interakcije, upotrebe i otisci lijekova - Zdravlje 2025
Aug 23, 2019
oldmedic.com
IMFINZI® (durvalumab)
Nov 14, 2018
imfinzi.com
Imfinzi durvalumab Global Market Report 2025: Key Drivers, Trends, Growth Opportunities, And Forecast
2 weeks ago
einpresswire.com
Dr. Gulley on Take Home Message With Olaparib Plus Durvalumab in mCRPC
Feb 17, 2018
onclive.com
Dr. Black Discusses the Impact of Durvalumab in Bladder Cancer
Jul 21, 2017
onclive.com
AZN : Imfinzi Plus Tremelimumab Show Unprecedented Survival In 1st-line Unresectable Liver Cancer
Jan 18, 2022
nasdaq.com
AstraZeneca's Imfinzi gets FDA priority review for small cell lung cancer
Nov 28, 2019
nasdaq.com
Imfinzi 500 Mg Injection
Jan 4, 2023
indiamart.com
HIMALAYA: Frontline Durvalumab Tremelimumab in Advanced HCC
Jul 20, 2022
onclive.com
1:03
FDA Prioritizes AstraZeneca’s Imfinzi for Small Cell Lung Cancer Patients
5 months ago
Microsoft News
Revolution Daily
FDA Approval of Durvalumab for Advanced Bladder Cancer
Apr 22, 2017
onclive.com
AstraZeneca receives new US approval for cancer drug Imfinzi
5 months ago
proactiveinvestors.co.uk
Dr. Feldman on Durvalumab for Patients With Lung Cancer
Nov 9, 2017
onclive.com
Dr. Black on Combinations with Durvalumab in Bladder Cancer
May 17, 2017
onclive.com
Dr. Patel on the FDA Approval of Durvalumab in NSCLC
Feb 17, 2018
onclive.com
Dr. Joshi Discusses Durvalumab and Radiation Therapy in Bladder Cancer
Feb 9, 2018
onclive.com
Dr. Girard on the Next Steps With Durvalumab in NSCLC
Oct 29, 2021
onclive.com
WCLC 2023 Insights: "ILLUMINATE - Efficacy & Safety of Durvalumab-Tremelimumab & Chemotherapy in EGFRm NSCLC Following Progression on EGFR Inhibitors"
78 views
Sep 23, 2023
vumedi.com
Dr. Feldman on the Future of Durvalumab and Tremilimumab in NSCLC
Nov 14, 2018
onclive.com
Dr. Balar on Impact of Durvalumab Plus Tremelimumab in Bladder Cancer
May 10, 2018
onclive.com
Dr. Sonpavde on Fixed-Dose Durvalumab and Tremelimumab Study in Urothelial Carcinoma
Feb 10, 2018
onclive.com
Dr. Zandberg on the Role of Durvalumab in Head and Neck Cancer
Oct 14, 2017
onclive.com
Dr. Ready on Selecting Between Frontline Atezolizumab and Durvalumab in ES-SCLC
Sep 7, 2021
onclive.com
Dr. Gulley Discusses a Phase II Study of Olaparib and Durvalumab in mCRPC
Feb 10, 2018
onclive.com
AstraZeneca's Imfinzi gets FDA priority review for type of lung cancer
5 months ago
theprint.in
Dr. Abdul Razak on Initial Findings With Durvalumab Plus Olaparib or Cediranib in Leiomyosarcoma
Sep 7, 2021
onclive.com
Dr. Singal on the FDA Approval of Durvalumab With Tremelimumab in Unresectable HCC
Dec 13, 2022
onclive.com
See more videos
Feedback
Feedback